Koncen Overview

  • Founded
  • 2001
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 3

Koncen General Information


Developer of medical technology intended to offer blood-purification. The company's technology helps to accelerate blood dialysis and blood purification adsorption, enabling healthcare providers to save the lives of the patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Number 8, Shenzhou Street, Science City
  • Luogang District
  • Guangzhou, Luogang 510660
  • China
+86 020 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Koncen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 29-Mar-2018 Completed Generating Revenue
1. Later Stage VC 01-Jan-2013 Completed Generating Revenue
To view Koncen’s complete valuation and funding history, request access »

Koncen Board Members (1)

Name Representing Role Since
Xiaoyuan Chen Koncen Board Member 000 0000
To view Koncen’s complete board members history, request access »

Koncen Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hyfinity Investments Venture Capital Minority 000 0000 000000 0
Sequoia Capital China Venture Capital Minority 000 0000 000000 0
Wen's Food Group Corporation Minority 000 0000 000000 0
To view Koncen’s complete investors history, request access »